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Abstract
Introduction and hypothesis In selected populations, pelvic
organ prolapse (POP) was associated with bladder/bowel
symptoms, but data on the general female population are
lacking. Our aim was to obtain normative data on the
prevalence of POP and pelvic floor dysfunction (PFD)
symptoms and signs and to identify associations.
Methods Validated questionnaires on POP and PFD (uro-
genital distress inventory, (UDI) and defaecation distress
inventory (DDI)) were sent to a general population of 2,979
women (aged 45–85 years). Data were analysed using the
Kruskal–Wallis test, chi square test and Spearman’s rank
correlation coefficient.
Results Response rate was 62.7%. Associations between
POP stage and parity (0.002) and vaginal bulging (<0.001)
are significant. Anatomical locations of POP and PFD
symptoms correlated significantly with incontinence of
flatus, feeling anal prolapse, manual evacuation of stool,
vaginal bulging, constipation and pain during faecal urge
(p≤0.005).
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Summary POP was strongly associated with obstructive bowel
disorders. Therefore, preventive strategies should be developed.
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Introduction
Dysfunction of the pelvic floor (PFD) can cause many
different symptoms, such as urinary or faecal incontinence
[1, 2], obstructed micturition or defaecation [3, 4], sexual
disorders [5–7], perineal pain [8] and vaginal bulging (a
specific symptom of clinically relevant pelvic organ
prolapse, POP) [9]. PFD symptoms are strongly associated
with the female gender [10]. Parity is strongly associated
with the development of PFD [11]. The impact of PFD
symptoms is substantial and multidimensional [12], which
underlines the need to gain more insight into associations
between the different symptoms.
In clinical practice, women often present with a complexity
of POP and bladder and/or bowel symptoms. Nevertheless,
only weak correlations were found between POP and other
bladder/bowel symptoms [13, 14]. It appears that women
with advanced POP are less likely to have stress urinary
incontinence (SUI) but more likely to have obstructed
micturition: SUI was only correlated with mild POP [15].
Recently, a stronger link has been demonstrated between
bladder/bowel symptoms and vaginal descent [16]. Interest-
ingly, not only the pelvic organ prolapse quantification
(POPQ) stages were tested for correlations with bladder and
bowel function, but also the anatomical location of POP were
studied using the nine-point notation of the POPQ. Strong
associations were found between bladder pain, obstructive
bladder symptoms and the lowest point of the most dependent
portion of the upper part of the anterior vaginal wall (point Ba).
and between bowel incontinence and the lowest point of most
dependent portion of the upper part of the posterior vaginal
wall (point Bp). Furthermore, the C-point was associated with
vaginal bulging. This suggests that progression of vaginal
descent over time is more strongly associated with these
bladder/bowel symptoms than has so far been demonstrated.
However, an association was found between POPQ location
and bladder/bowel symptoms in a selected group of meno-
pausal women, but the selection might have distorted the
outcome. In 2005, Kahn et al. reported an association between
faecal straining in combination with anterior vaginal wall and
perineal descent in a selected population of women who
visited the gynaecological clinic [17].
It is unclear whether the associations between POP and
bladder/bowel symptoms are also present in a general
female population.
We therefore conducted a cross-sectional study to obtain
normative data on the prevalence of pelvic floor dysfunction
symptoms using questionnaires and vaginal examination.
POPQ scores were tested in relation with age and parity. We
also analysed associations between the pelvic floor symp-
toms and POPQ stages as well as the nine-point notation.
Materials and methods
A cross-sectional study was performed on a general
population of Dutch, mostly white women aged 45 to
85 years. Figure 1 presents the flowchart of the study.
The total population of women aged 45–85 years,
registered in the office records of eight out of nine general
practitioners from the town of Brielle (near Rotterdam, the
Netherlands), were approached to participate in the present
study. Since all inhabitants have the obligation to be registered
at a general practitioners clinic, the study population contained
95% of all women in Brielle in this age category. The women
were sent information about the study and enrolled by filling
out an informed consent form. They were offered three options:
to sign a refusal form, to fill out the questionnaire only or to
fill out the questionnaire and undergo vaginal examination.
All the women were asked to complete a self-report
questionnaire. Non-responders received a reminder 8 weeks
after the first contact that contained the same questionnaire.
The data were collected anonymously. To avoid selection
bias, non-responders were invited to complete a short
questionnaire that comprised five questions about: age,
parity, presence of stress urinary incontinence (yes/no), faecal
incontinence (yes/no) and feeling a vaginal bulge (yes/no).
To encourage a high response to the questionnaire, we used
envelopes with the name and logo of the Erasmus University,
coloured paper and stamped-addressed return envelopes [18].
The questionnaire used in this study combined Dutch-
validated versions of pelvic floor questionnaires, such as the
urogenital distress inventory (UDI) [19] and the defaecation
distress inventory (DDI) [2]. In addition, women were asked
about body mass index (BMI) ethnicity, educational level,
parity, menopausal status, hormone replacement therapy
(HRT), smoking, previous pelvic floor surgery, family
history and heavy physical work currently or in the past.
Women were classified as symptomatic if they reported
feeling and/or seeing vaginal bulging on the questionnaires.
Differences in vaginal bulging, stress urinary incontinence
(urine loss ≥1/month with at least a little bother) and faecal
incontinence (loss of fluid or solid stool ≥1/month with at
least little bother) were tested between the non-responders
and responders using the outcomes on the UDI and DDI.
Women were defined symptomatic on bladder and bowel
symptoms with the same criteria as mentioned for the
vaginal bulging. Frequency of symptoms had to be reported
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at least ≥1/month and the bother was reported at least as ‘a
little bother’.
Differences in vaginal bulging, stress urinary inconti-
nence and faecal incontinence (loss of solid stool ≥1/month
with at least little bother) were tested between the non-
responders and responders using the outcomes on the UDI
and DDI.
Vaginal examination
From all the participants who gave informed consent to
undergo vaginal examination, we randomly selected women
for POPQ measurement (all response forms of the women
were registered with a number that identified the age and they
were at random taken by a research assistant). The POPQ was
introduced by the International Continence Society (ICS). It
has become widely accepted and proven to be valid [20] and
reliable [21]. One gynaecologist and one physiotherapist
performed the vaginal examinations (every woman was
examined by the gynaecologist or the physiotherapist). They
practiced the vaginal examination protocol until both exam-
iners were scoring same results. POPQ measurements were
carried out in conformity with the ICS standardisation report
[20]. After each examination, all the details were entered into
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Fig. 1 Flowchart of the study
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the three-by-three POPQ grid. The two examiners were
blinded to the results of the questionnaire. The women were
asked to empty their bladder before the examination.
Women were assigned to one of five ordinal stages of
prolapse (0–4) in accordance with the POPQ grading
system. All methods, definitions and descriptions were in
line with the ICS. Furthermore, we used the notation of the
nine-point grid of the POPQ to analyse possible correla-
tions between the different points of the POPQ.
Statistical analysis
Patient characteristics were compared between the POPQ
stages and the symptomatic and asymptomatic women by
means of the Kruskal–Wallis test and the chi square test for
continuous and categorical variables, respectively. Spear-
man’s rank correlation coefficient was calculated between
the components of the nine-point grid of the POPQ and the
items from the UDI and DDI questionnaires. The analyses
were performed using the Statistical Package for Social
Science (SPSS Inc) 15.0. The Medical Ethics Research
Committee (METC) of the Erasmus Medical Centre in
Rotterdam, the Netherlands, approved this study.
Results
Response rate
The response rate to the questionnaire was 62.7% (1,869/
2,979). In the group of 1,869 responders, 472 (25.2%)
women refused to participate, 1,397 (74.8%) women (group
1 in Table 1) agreed to fill out the large questionnaire and
1,140 (group 2; 60.9%) agreed to fill out the questionnaire
and undergo vaginal examination. From group 2, 800 women
were selected at random and sent an invitation to undergo
vaginal examination. All response forms of the women were
registered with a number that identified the age and they were,
at random, taken by a research assistant. Six-hundred forty-
nine women participated (81.1%) in the vaginal examination.
So, of the total study group of 1,397, 46.4% were vaginally
examined. The study group of 649 women was stratified into
an asymptomatic control group (n=570) and a symptomatic
(n=79) group in which the women had reported seeing
and/or feeling vaginal bulging. In the non-responder group
3, 59% returned the completed short questionnaire (620/
1,051). Vaginal bulging was reported by 6.7% (n=41) of
this non-responder group versus 9.8% in the responder
group (135/1,397). Combining the data on the large- and
short questionnaires from the responders (group 1) and the
initial non-responders (group 3; 1,397+620=2,017)
revealed a prevalence rate of 8.7% (n=176) of feeling
vaginal bulging.
Baseline characteristics
Baseline characteristics of the total study population and
the different groups (overall group 1, the vaginal exam-
ination group 2 divided into a symptomatic group (seeing
and/or feeling vaginal bulging) and an asymptomatic
group and the non-responder group 3) are presented in
Table 1.
No significant differences were found between group 1
and group 3, or between the asymptomatic and symptom-
atic women in group 2.
Prevalence
The prevalence of POP per stage in relation with age in our
general population is presented in Table 2. No significant
association could be demonstrated between increasing
age and increasing POP. In the analysis of the prevalence
of POP in relation with parity, there was a significant
association between POP stage and a parity of two (0.002).
No significant association was demonstrated between POP
stage and a parity of ≥3.
In the vaginal examination group, the symptoms of
pelvic floor dysfunction are shown in relation with the
POPQ stages in Table 3. The only significant correlation
between POP stage and bladder and/or bowel symptoms
was with vaginal bulging (p<0.001). In Table 4, the
symptoms of pelvic floor dysfunction are presented versus
the nine-point notation of the POPQ measurement.
Significant correlations (shown with asterisks) were found
with incontinence of flatus, anal prolapse, manual evacu-
ation of stool per vagina and/or anus, vaginal bulging,
constipation and pain during faecal urge (p≤0.05). This
demonstrated a strong association between the posterior
vaginal wall and bowel disorders, as well as an association
between bladder disorders and the anterior vaginal wall.
Table 5 presents the detailed POPQs in relation with feeling
and/or seeing vaginal bulging. The only non-significant
locations were the genital hiatus, perineal length and total
vaginal length.
Discussion
In this study on mainly white women aged 45–85 years
from the general population, the prevalence of bladder and
bowel disorders was high. We found a relation between the
anterior compartment prolapse and urge urinary inconti-
nence as well as a significant association between posterior
compartment prolapse and bowel disorders. Analysis of the
anatomical location of the POP led to these significant
findings. The overall POPQ stage did not show any
associations besides the symptom of vaginal bulging.
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Prevalence of symptoms according to self-report
questionnaires
In our overall group, the prevalence of feeling and/or seeing
vaginal bulging in the overall group was 12.1%: 9.7% reported
the feeling of vaginal bulging alone. These figures are
comparable with the prevalence of 8.3% (95% CI 7.3–9.1)
reported in a Swedish population study [11]. In another Swedish
study, only 4% had a positive POP score. However, they used
other inclusion criteria and dichotomized the study population
according to age and they defined a POP as a positive score
on the question ‘do you experience a sense of heaviness in
the lower abdomen’. [22]. MacLennan et al. reported an 8%
prevalence of POP in a general population [10]. They
Table 1 Characteristics of total study group, the vaginal exam group and the non-responders group
Characteristics of the study
population















n=1,397 n=1,214 n=159 (11.4 %) n=570 n=79 (12.2%) n=620
58.0 (SD±9.2) 57.8 (SD±9.1) 59.0 (SD±9.5) 58.0 (SD±8.9) 59.3 (SD±9.1) 59.2
Mean BMI 25.6 (SD±3.9) 25.6 (SD±4.0) 25.5 (SD±3.4) 25.6±3.7 25.5±3.1
Race (n=1,340) n=1,165 (n=153) (n=551) (n=78)
White 1,351 (98.4) 1,172 (88.2) 156 (98.1) 545 (98.7) 78 (100)
Non-white 20 (1.5) 18 (1.3) 1(0.6) 7 (1.3) 0
Educational level (n=1,374) (n=1,193) (n=158) (n=556) (n=78)
Primary only 139 (9.9) 117 (9.8) 18 (11.4) 63 (11,3) 7 (8.9)
Intermediate 1,039 (75.6) 907 (76) 117 (74.1) 420 (75.5) 60 (76.9)
Higher 196 (14.3) 169 (14.2) 23 (14.6) 493 (88.6) 71 (91)
Median parity 2 2 2 2 2 2
0 120 (8.9) 110 (9.4) 9 (5.8) 46 (8.3) 3 (3.8) 67 (10.6)
1 215 (16) 184 (15.8) 25 (16.3) 71 (12.9) 13 (16.6) 102 (16.1)
2 675 (50.3) 582 (49.9) 87 (56.8) 273 (49.5) 46 (58.9) 277 (43.6)
≥3 387 (28.8) 338 (29) 38 (24.8) 161 (29.2) 16 (20.5) 180 (28.3)
Menopausal status (n=1,383) (n=1,202) (n=159) (n=557) (n=79)
(Pre)menopausal 374 (27) 332 (27.6) 39 (24.5) 151 (27.1) 16 (20.2)
Postmenopausal 1,009 (72.9) 870 (72.4) 120 (75.5) 406 (72.9) 63 (79.7)
(Pre)menopausal with HRT (n=1,361) (n=332) (n=38) (n=551) (n=79)
(Pre)menopausal with HRT 24 (1.7) 22 (6.6) 2 (5.3) 9 (1.6) 0
Postmenopausal with HRT 63 (4.6) 52 (15.6) 10 (26.3) 23 (4.2) 7 (8.9)
Smoking (n=1,382) (n=1,202) (n=158) (n=556) (n=78)
Current Smoker 280 (20.2) 248 (22.4) 29 (10.5) 117 (21) 16 (20.5)
Ever Smoker 345 (46.3) 300 (46.6) 43 (12.5) 158 (54.8) 25 (64.1)
Surgical history (n=1,384) (n=1,202) (n=159) (n=557) (n=79)
Prolapse 103 (7.4) 71 (5.9) 29 (18.2)* 0.000 37 (6.6) 16 (20.2)
Incontinence 47 (3.4) 36 (2.9) 10 (6.4) 0.032 21 (3.8) 3 (3.9)
Hysterectomy 234 (16.9) 191 (15.8) 36 (22.6) 0.024 85 (15.3) 20 (25.3)
Family history (n=985) (n=874) (n=97) (n=397) (n=44)
Mother POP 359 (26.4) 304 (34.8) 50 (51.5)* 0.001 139 (35 ) 22 (50)
(n=870) (n=784) (n=86) (n=357) (n=41)
Mother UI 258 (29.6) 222 (28.3) 36 (41.9) 0.008 106 (29.7) 16 (39)
Heavy physical work n=1,381 (n=1,198) (n=159) (n=553) (n=79)
Current 269 (19.3) 227 (18.9) 39 (24.5) 109 (19.7) 18 (22.8)
n=1,384 (n=1,201) (n=159) (n=556) (n=79)
Ever 619 (44.3) 531 (44.2) 78 (49.1) 248 (44.6) 39 (49.3)
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defined a positive POP symptom based on the question ‘do
you have a feeling of something coming down in the vagina.’
Furthermore, their age group was age 15 to ≥65 years
(28% were nulliparous and the number of deliveries in the
parous group was unknown). They asked all the questions in
a face-to-face interview, which may have led to different
answers from those given on self-report questionnaires [23].
Prevalence of signs scored with the POPQ grading system
In our general population, the percentage of women in the
five ordinal POPQ stages (0–4) were 25%, 36.5%, 33%,
5% and 0.5%, respectively.
The prevalence of POP in a general population has only
been determined using the POPQ grading system in a few
studies. Our percentages in the five POP stages in the
asymptomatic group 2, who did not report seeing and/or
feeling vaginal bulging were comparable with those in the
asymptomatic group in the study by Digesu et al. [24].
However, there was a difference in mean age (48 years),
which indicates that age may not be responsible for this
comparable result, which also can be concluded from our
findings that age and POP stage were not significant
associated. In contrast, the data on the symptomatic group
differed, probably due the different choice of definition of
‘symptomatic’. In their symptomatic group, Digesu et al.
Table 3 Symptoms of pelvic floor disorders in the vaginal examination group versus the POPQ grading system in %
n Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Overall
Urinary incontinence
Urge urinary incontinence 625 27.8 30.1 31.7 40.0 33.3 30.5
Stress urinary incontinence 627 53.5 59.6 54.6 43.3 33.3 53.9
Mixed urinary incontinence 624 22.2 25.4 25.9 16.7 0 24.2
Faecal incontinence
Flatus 638 46.9 46.4 54.5 58.1 33.3 49.6
Fluid stool 638 15.0 8.2 15.6 9.7 0 12.3
Solid stool 641 3.7 2.6 5.7 6.5 0 4
Obstructive micturition
Difficulty emptying bladder 631 14.5 17.7 20.7 33.3 33.3 18.7
Bladder not empty after micturition 636 26.4 24.8 33.3 40.0 33.3 28.7
Obstructive defaecation
False faecal urge 638 27.7 30.0 35.4 29.0 33.3 31.1
Feeling of anal prolapse 634 15.2 12.9 19.9 16.7 66.7 16.2
Manual evacuation of stool per vagina 633 12.7 14.4 16.0 22.6 33.3 15
Manual evacuation of stool per anus 639 8.1 7.7 10.0 6.5 0 8.4
Frequent straining during defaecation 637 27.8 27.9 30.2 35.5 0 3.5
Vaginal bulging 633 7.6* 6.9* 15.8* 43.3* 100* 12.1
Constipation 637 7.5 4.3 4.7 0 0 5
Pain
Low abdominal 634 24.7 22.7 28.7 32.3 33.3 25.7
During faecal urge 633 10.8 7.8 11.8 19.4 0 10.4
During/after defaecation 632 12.7 10.4 14.2 16.1 0 13.6
*p value <0.001 chi square test
Age (years) Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Total
45–50 24 (16.4) 66 (45.2) 53 (36.3) 3 (2.1) 0 146
>50–55 39 (26.9) 57 (39.3) 42 (29.0) 7 (4.8) 0 145
>55–60 47 (34.1) 39 (28.3) 45 (32.6) 7 (5.1) 0 138
>60–65 16 (20.5) 30 (38.5) 25 (32.1) 7 (9.0) 0 78
>65–70 21 (33.9) 17 (27.4) 22 (35.5) 2 (3.2) 0 62
>70 14 (18.9) 26 (35.1) 25 (33.8) 6 (8.1) 3 (4.1) 74
Overall 161 (25.0) 235 (36.5) 212 (33.0) 32 (5.0) 3 (0.5) 643
Table 2 Overall distribution of
POP per age group (%)
Chi square test for trend was
used (p<0.001)
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included all the women with any type of prolapse
complaints, such as bladder and bowel dysfunction and
those who reported a ‘sensation of dragging’ or ‘a lump or
fullness in the vagina’.
In the literature, various populations of women have
been studied. At first sight, the results of the prevalence of
POP measured with the POPQ seems most comparable with
the results reported by Swift [21] and Kahn [17], but they
only recruited women who were receiving routine gynae-
cological health care. Thus, the characteristics of the study
populations differed with respect to ethnicity, parity, BMI,
age, surgical history and menopausal status, which hampers
comparison of the prevalence rates in the POP stages.
In the prevalence study conducted by Nygaard et al.,
older women were enrolled from the Women’s Health
Initiative Hormone Replacement (WHIHR) [25]. Their
results are not comparable with ours due to the different
age groups, BMI and the HRT (mean age 68.2 years, BMI
30.4). Furthermore, according to Nygaard et al., some
degree of POP is nearly ubiquitous in older women.
However, in our study, we did not observe a significant
increase in POP with increasing age. The differences can
probably be explained by patient selection, with different
HRT scores, BMI and heavy physical work [26, 27] in the
population studied by Nygaard et al.
Table 5 Detailed POPQ scores in the symptomatic and asymptomatic
women with p value ≤0.005 Kruskal–Wallis was used to analyse the
median and the range (in parenthesis)
Bulging No bulging p value
aa −2 (−3, 3) −3 (−3, 1) 0.000
ba −1 (−3, 6) −2 (−4, 3) 0.000
c −5 (−8, 6) −6 (−9, 3) 0.000
gh 4 (2, 6) 4 (1, 8) 0.257
pb 3 (1, 6) 3 (1, 6) 0.601
tvl 9 (5, 10) 9 (3, 11) 0.012
ap −2 (−3, 3) −3 (−3, 3) 0.001
bp −2 (−3, 6) −2 (−3, 3) 0.005
d −7 (−9, 1) −7 (−9, −1) 0.000
Values in italics are significant
Table 4 Symptoms of pelvic floor disorders versus the nine-point grid of the first notation of the POPQ with significance in italics
aa ba c hg per tvl ap bp d
Urinary incontinence
Urge urinary incontinence −0.03 −0.08*** 0.01 −0.06 0.06 −0.02 0.05 0.03 −0.01
Stress urinary incontinence −0.03 −0.01 0.00 −0.05 0.02 −0.02 0.07 0.06 −0.02
Mixed urinary incontinence 0.02 0.06 −0.02 0.04 −0.06 −0.01 −0.06 −0.05 0.00
Faecal incontinence
Flatus −0.06 −0.06 0.01 −0.04 0.06 0.03 −0.09**** −0.11** 0.01
Fluid stool 0.01 −0.01 0.02 −0.02 −0.08 0.05 0.02 0.00 0.03
Solid stool −0.01 −0.04 0.03 −0.02 −0.03 0.05 0.02 0.04 −0.03
Obstructive micturition
Difficulty emptying bladder −0.02 −0.05 −0.02 −0.02 0.00 −0.01 −0.06 −0.07 −0.02
Bladder not empty after micturition −0.03 −0.02 −0.03 −0.04 −0.07 0.00 −0.07 −0.04 −0.06
Obstructive defaecation
False faecal urge −0.05 −0.07 −0.01 0.04 0.00 0.05 −0.02 −0.05 −0.01
Feeling of anal prolapse −0.02 −0.03 0.00 −0.03 −0.09**** 0.01 −0.03 −0.08***** 0.00
Manual evacuation of stool per vagina −0.04 0.01 −0.01 −0.02 0.06 0.00 −0.08***** −0.11* −0.03
Manual evacuation of stool per anus −0.02 −0.01 −0.04 0.07 −0.09**** 0.11* −0.02 −0.02 −0.06
Frequent straining during defaecation 0.02 0.02 0.02 −0.04 0.03 −0.01 −0.02 −0.09* −0.02
Vaginal bulging −0.18* −0.18* −0.14* −0.05 0.02 0.10** −0.14* −0.11* −0.16*
Constipation 0.07 0.07 0.08*** 0.08*** −0.05 0.02 0.05 0.06 0.03
Pain
Low abdominal −0.03 −0.02 −0.01 −0.02 −0.10* −0.04 −0.09* −0.06 −0.04
During faecal urge −0.04 −0.04 −0.08 −0.01 −0.04 −0.04 −0.04 −0.07 −0.05
During/after defecation −0.01 0.00 0.01 0.03 −0.02 −0.02 0.00 −0.03 −0.03
Spearman’s rank correlation coefficient was calculated between the components of the nine-point grid of the POPQ and the items from the UDI
and DDI incontinence questionnaires
*p 0.000; **p 0.01; ***p 0.04; ****p 0.03; *****p 0.05
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In our study, POP complaints were present in 3.8% of
the nulliparous women. This indicates that childbirth is not
a prerequisite for POP, although Boyle et al. demonstrated
that pregnancy was associated with increased POP stages
compared to nulliparous women [26]. In our study, the
median parity in the symptomatic and asymptomatic groups
was similar (2). In the vaginal examination group, there was
a significant (p 0.002) increase in POP with increasing
parity, especially after the second child (OR 1.8). This is in
line with the study by Mant et al. [28] who demonstrated
that women with two children were 8.4 times more likely to
develop POP that required hospital admission.
Pelvic floor symptoms versus POP signs measured
with the POPQ, analysed with the grading system 0–4
In our study, no significant correlations were found between
the pelvic floor symptoms of bladder and/or bowel
disorders. However, we did find a significant correlation
with ‘seeing and/or feeling vaginal bulging’. Similar to the
results of many other studies [10, 13, 21], we observed
strong discrepancies between the symptoms and signs.
Therefore, we emphasise the need for a clinically relevant
definition of POP that is not only based on anatomical
findings, but also on the symptoms.
Pelvic floor symptoms versus POP location measured
with the POPQ, analysed with the nine-point notation
Although no significant correlations could be demonstrated
between the pelvic floor symptoms and the ordinal POP
stage (0-4 of the POPQ), many significant correlations were
found between the anatomical locations of the nine-point
notation. The presence of urge urinary incontinence was
significantly associated with the lowest point of the upper
anterior vaginal wall. This has been demonstrated in earlier
studies and urge urinary incontinence disappeared or
diminished after successful surgical correction of the
anterior vaginal wall [29].
Our results differed from those reported by Bradley et
al. [16]. Bladder pain and obstructive bladder symptoms
were significantly associated with the lowest point of the
upper anterior vaginal wall, but not with the presence of
urge urinary incontinence. Overall, most of the significant
associations were with obstructive bowel disorders: feeling
of anal prolapse, manual evacuation of stool per vagina and
per anus. Constipation and vaginal bulging were signifi-
cantly associated with apical support and the genital hiatus.
This is in line with the findings reported by Klingele et al.
[4]. POP severity was lower in their faecal incontinence
group than in their obstructive bowel symptom group. The
study by Bradley also demonstrated that vaginal bulging
was associated with point C [16]. Our point C results
contrasted with the study by Kahn [17], in which they did
not find any significant association with constipation.
However, Kahn et al. reported similar results on the
need for manual evacuation of stool and straining
associated with the lowest point on the upper posterior
vaginal wall (point Bp). Therefore, the posterior vaginal
wall is strongly associated with bowel disorders, including
incontinence of flatus. It is likely that anatomical changes
in the posterior vaginal wall are partly responsible for this
symptom.
To analyse associations between POP symptoms and
signs and bladder/bowel disorders in a general population,
the POPQ grading system did not show as many significant
associations as the nine-point notation. This is not surpris-
ing because the POPQ grading system only takes the most
severely prolapsed compartment into account, which is not
necessarily the compartment responsible for the most
relevant symptoms. This demonstrates the need to present
details about compartments when reporting on the preva-
lence of POP.
Strengths and limitations
POP varies between different ethnicities [30]. One of the
strengths of our study was the ethnic homogeneity, because
almost all of the women were white, which eliminated
racial bias in the results. Furthermore, broad data were
obtained from a large study group using a combination of
questionnaires and vaginal examination.
Although this study was performed on a general
population, the mean BMI of 25 and the 98% white race
may have negative effects on extrapolation to other general
populations. Also some selection bias could be present due
to the women who participated in a vaginal examination
and perhaps were symptomatic and never sought help in the
past. Our data demonstrated important associations between
bladder/bowel disorders and POP that will help to support
the development of preventive strategies for pelvic floor
disorders.
Conclusions
The prevalence of bladder and bowel disorders was high.
Anterior compartment prolapse was related to urge urinary
incontinence. Posterior compartment prolapse was associ-
ated with bowel disorders. To demonstrate significant
associations between the presence of POP and bowel/
bladder disorders, it is essential to analyse not only the
overall POPQ stages, but also the prolapse severity in the
three compartments. As POP was found to be strongly
associated with obstructive bowel disorders, preventive
strategies need to be developed.
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